These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4235919)

  • 21. Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat.
    Kromer EP; Riegger GA
    Am J Cardiol; 1988 Jul; 62(1):161-3. PubMed ID: 2837894
    [No Abstract]   [Full Text] [Related]  

  • 22. [DYNAMICS OF CHANGES IN THE STRUCTURE AND MASS OF MITOCHONDRIA OF THE HEART DURING THE PROCESS OF ITS HYPERFUNCTION AND HYPERTROPHY].
    MEERSON FZ; ZALETAEVA TA; LAGUCHEV SS; PSHENNIKOVA MG
    Tsitologiia; 1964; 6(5):559-66. PubMed ID: 14277047
    [No Abstract]   [Full Text] [Related]  

  • 23. [Proportion and number of muscle cells with different numbers of neclei in the left ventricular myocardium of mice with hypertrophy caused by constriction of the ascending aorta].
    Kogan ME; Belov LN
    Tsitologiia; 1978 Jun; 20(6):712-7. PubMed ID: 151362
    [No Abstract]   [Full Text] [Related]  

  • 24. Ventricular hypertrophy induced by mineralocorticoid treatment or aortic stenosis differentially regulates the expression of cardiac K+ channels in the rat.
    Capuano V; Ruchon Y; Antoine S; Sant MC; Renaud JF
    Mol Cell Biochem; 2002 Aug; 237(1-2):1-10. PubMed ID: 12236575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Electron microscopic studies of the myocardial hypertrophy in inherited myopathy of the syrian hamster].
    Onishi E; Bajusz E; Büchner F; Rickers K
    Beitr Pathol Anat; 1970; 140(2):119-91. PubMed ID: 4246107
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ultrastructural changes in human myocardium with hypertrophy due to aortic valve disease and their relationship to left ventricular mass and ejection fraction (author's transl)].
    Schaper J; Schwarz F; Hehrlein F
    Herz; 1981 Aug; 6(4):217-25. PubMed ID: 6455374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural analysis of left ventricular hypertrophy in rabbits.
    Goldstein MA; Sordahl LA; Schwartz A
    J Mol Cell Cardiol; 1974 Jun; 6(3):265-73. PubMed ID: 4837897
    [No Abstract]   [Full Text] [Related]  

  • 28. Alterations of myocardial blood flow associated with experimental canine left ventricular hypertrophy secondary to valvular aortic stenosis.
    Alyono D; Anderson RW; Parrish DG; Dai XZ; Bache RJ
    Circ Res; 1986 Jan; 58(1):47-57. PubMed ID: 2935324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Architecture of coronary vessels in experimental myocardial hypertrophy].
    Ljungqvist A; Unge G
    Nord Med; 1971 Apr; 85(15):481. PubMed ID: 4252510
    [No Abstract]   [Full Text] [Related]  

  • 30. [Early morphological changes during the development of cardiac hypertrophy (author's transl)].
    Hort W; Novi AM; Frenzel H
    Arzneimittelforschung; 1980; 30(11a):2008-11. PubMed ID: 6452128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI evaluation of left ventricular hypertrophy in a canine model of aortic stenosis.
    Wang JZ; Mezrich RS; Scholz P; Als A; Douglas F
    Invest Radiol; 1990 Jul; 25(7):783-8. PubMed ID: 2143994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A MECHANISM OF HYPERTROPHY AND WEAR OF THE MYOCARDIUM.
    MEERSON FZ
    Am J Cardiol; 1965 Jun; 15():755-60. PubMed ID: 14295866
    [No Abstract]   [Full Text] [Related]  

  • 33. Alterations in the regional beta adrenergic system in experimental left ventricular hypertrophy.
    Scholz PM; Upsher ME; Eliades D; Kedem J; Weiss HR
    Cardiovasc Res; 1990 Jan; 24(1):65-71. PubMed ID: 2158400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphometric analysis of cardiac hypertrophy: left ventricular shape and number of muscle-fiber layers across left ventricular wall.
    Tezuka F
    Tohoku J Exp Med; 1982 Sep; 138(1):1-6. PubMed ID: 6216626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The proteosynthetic system of heart muscle in the process of development of experimental cardiac hypertrophy].
    Kél'bel F; Mommaérts VF; Kél'belova V
    Kardiologiia; 1968 Feb; 8(2):78-81. PubMed ID: 4232107
    [No Abstract]   [Full Text] [Related]  

  • 36. [Is secondary myocardial hypertrophy a physiological or pathological adaptive mechanism?].
    Krayenbühl HP
    Z Kardiol; 1982 Aug; 71(8):489-96. PubMed ID: 6215776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of angiotensin converting enzyme inhibition on pressure-induced left ventricular hypertrophy in rats.
    Zierhut W; Zimmer HG; Gerdes AM
    Circ Res; 1991 Sep; 69(3):609-17. PubMed ID: 1714799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleotide content of ribonucleic acid in compensatory hyperfunction and hypertrophy of the heart.
    Meerson FZ; Kopteva LA; Melechov VV; Markovskaya GJ
    Nature; 1966 Nov; 212(5065):927-8. PubMed ID: 6004576
    [No Abstract]   [Full Text] [Related]  

  • 39. Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy.
    Maron BJ; Ferrans VJ; Roberts WC
    Am J Pathol; 1975 Jun; 79(3):387-434. PubMed ID: 124533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ultrastructure of the myocardium in heart failure--with reference to cardiac hypertrophy].
    Kawamura K
    Saishin Igaku; 1970 Jan; 25(1):19-24. PubMed ID: 4245861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.